According to our latest study, the global Anti-infectious Disease Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Anti-infectious Disease Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Anti-infectious Disease Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Anti-infectious Disease Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Anti-infectious Disease Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Anti-infectious Disease Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-infectious Disease Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-infectious Disease Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aridis Pharmaceuticals, AiCuris, Sandoz, Anhui Jingfang Medical Industry Co.,Ltd and Beijing Double-Crane Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Anti-infectious Disease Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs
Antiparasitic Drugs
Market segment by Application
Hospital
Institute of Medicine
Clinic
Others
Major players covered
Aridis Pharmaceuticals
AiCuris
Sandoz
Anhui Jingfang Medical Industry Co.,Ltd
Beijing Double-Crane Pharmaceutical Co., Ltd.
Abbott
Spero Therapeutics
Adlyfe, Inc.
Advanced Life Sciences Holdings, Inc.
Affinium Pharmaceuticals
APP Pharmaceuticals
Aquapharm Biodiscovery
Basilea Pharmaceutica AG
Biophage Pharma, Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-infectious Disease Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-infectious Disease Drugs, with price, sales, revenue and global market share of Anti-infectious Disease Drugs from 2018 to 2023.
Chapter 3, the Anti-infectious Disease Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-infectious Disease Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Anti-infectious Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-infectious Disease Drugs.
Chapter 14 and 15, to describe Anti-infectious Disease Drugs sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Anti-infectious Disease Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-infectious Disease Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Antibacterial Drugs
1.3.3 Antifungal Drugs
1.3.4 Antiviral Drugs
1.3.5 Antiparasitic Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-infectious Disease Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Institute of Medicine
1.4.4 Clinic
1.4.5 Others
1.5 Global Anti-infectious Disease Drugs Market Size & Forecast
1.5.1 Global Anti-infectious Disease Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-infectious Disease Drugs Sales Quantity (2018-2029)
1.5.3 Global Anti-infectious Disease Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Aridis Pharmaceuticals
2.1.1 Aridis Pharmaceuticals Details
2.1.2 Aridis Pharmaceuticals Major Business
2.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product and Services
2.1.4 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Aridis Pharmaceuticals Recent Developments/Updates
2.2 AiCuris
2.2.1 AiCuris Details
2.2.2 AiCuris Major Business
2.2.3 AiCuris Anti-infectious Disease Drugs Product and Services
2.2.4 AiCuris Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AiCuris Recent Developments/Updates
2.3 Sandoz
2.3.1 Sandoz Details
2.3.2 Sandoz Major Business
2.3.3 Sandoz Anti-infectious Disease Drugs Product and Services
2.3.4 Sandoz Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sandoz Recent Developments/Updates
2.4 Anhui Jingfang Medical Industry Co.,Ltd
2.4.1 Anhui Jingfang Medical Industry Co.,Ltd Details
2.4.2 Anhui Jingfang Medical Industry Co.,Ltd Major Business
2.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product and Services
2.4.4 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Anhui Jingfang Medical Industry Co.,Ltd Recent Developments/Updates
2.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
2.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Details
2.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Major Business
2.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product and Services
2.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Anti-infectious Disease Drugs Product and Services
2.6.4 Abbott Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abbott Recent Developments/Updates
2.7 Spero Therapeutics
2.7.1 Spero Therapeutics Details
2.7.2 Spero Therapeutics Major Business
2.7.3 Spero Therapeutics Anti-infectious Disease Drugs Product and Services
2.7.4 Spero Therapeutics Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Spero Therapeutics Recent Developments/Updates
2.8 Adlyfe, Inc.
2.8.1 Adlyfe, Inc. Details
2.8.2 Adlyfe, Inc. Major Business
2.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Product and Services
2.8.4 Adlyfe, Inc. Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Adlyfe, Inc. Recent Developments/Updates
2.9 Advanced Life Sciences Holdings, Inc.
2.9.1 Advanced Life Sciences Holdings, Inc. Details
2.9.2 Advanced Life Sciences Holdings, Inc. Major Business
2.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product and Services
2.9.4 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Advanced Life Sciences Holdings, Inc. Recent Developments/Updates
2.10 Affinium Pharmaceuticals
2.10.1 Affinium Pharmaceuticals Details
2.10.2 Affinium Pharmaceuticals Major Business
2.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product and Services
2.10.4 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Affinium Pharmaceuticals Recent Developments/Updates
2.11 APP Pharmaceuticals
2.11.1 APP Pharmaceuticals Details
2.11.2 APP Pharmaceuticals Major Business
2.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Product and Services
2.11.4 APP Pharmaceuticals Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 APP Pharmaceuticals Recent Developments/Updates
2.12 Aquapharm Biodiscovery
2.12.1 Aquapharm Biodiscovery Details
2.12.2 Aquapharm Biodiscovery Major Business
2.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product and Services
2.12.4 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Aquapharm Biodiscovery Recent Developments/Updates
2.13 Basilea Pharmaceutica AG
2.13.1 Basilea Pharmaceutica AG Details
2.13.2 Basilea Pharmaceutica AG Major Business
2.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product and Services
2.13.4 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Basilea Pharmaceutica AG Recent Developments/Updates
2.14 Biophage Pharma, Inc.
2.14.1 Biophage Pharma, Inc. Details
2.14.2 Biophage Pharma, Inc. Major Business
2.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product and Services
2.14.4 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Biophage Pharma, Inc. Recent Developments/Updates
3 Competitive Environment: Anti-infectious Disease Drugs by Manufacturer
3.1 Global Anti-infectious Disease Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-infectious Disease Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Anti-infectious Disease Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-infectious Disease Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-infectious Disease Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-infectious Disease Drugs Manufacturer Market Share in 2022
3.5 Anti-infectious Disease Drugs Market: Overall Company Footprint Analysis
3.5.1 Anti-infectious Disease Drugs Market: Region Footprint
3.5.2 Anti-infectious Disease Drugs Market: Company Product Type Footprint
3.5.3 Anti-infectious Disease Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Anti-infectious Disease Drugs Market Size by Region
4.1.1 Global Anti-infectious Disease Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-infectious Disease Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Anti-infectious Disease Drugs Average Price by Region (2018-2029)
4.2 North America Anti-infectious Disease Drugs Consumption Value (2018-2029)
4.3 Europe Anti-infectious Disease Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-infectious Disease Drugs Consumption Value (2018-2029)
4.5 South America Anti-infectious Disease Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-infectious Disease Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
5.2 Global Anti-infectious Disease Drugs Consumption Value by Type (2018-2029)
5.3 Global Anti-infectious Disease Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
6.2 Global Anti-infectious Disease Drugs Consumption Value by Application (2018-2029)
6.3 Global Anti-infectious Disease Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
7.2 North America Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
7.3 North America Anti-infectious Disease Drugs Market Size by Country
7.3.1 North America Anti-infectious Disease Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-infectious Disease Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Anti-infectious Disease Drugs Market Size by Country
8.3.1 Europe Anti-infectious Disease Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-infectious Disease Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-infectious Disease Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-infectious Disease Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
10.2 South America Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
10.3 South America Anti-infectious Disease Drugs Market Size by Country
10.3.1 South America Anti-infectious Disease Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-infectious Disease Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-infectious Disease Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-infectious Disease Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Anti-infectious Disease Drugs Market Drivers
12.2 Anti-infectious Disease Drugs Market Restraints
12.3 Anti-infectious Disease Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Anti-infectious Disease Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-infectious Disease Drugs
13.3 Anti-infectious Disease Drugs Production Process
13.4 Anti-infectious Disease Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-infectious Disease Drugs Typical Distributors
14.3 Anti-infectious Disease Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Anti-infectious Disease Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-infectious Disease Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Aridis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Aridis Pharmaceuticals Major Business
Table 5. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product and Services
Table 6. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Aridis Pharmaceuticals Recent Developments/Updates
Table 8. AiCuris Basic Information, Manufacturing Base and Competitors
Table 9. AiCuris Major Business
Table 10. AiCuris Anti-infectious Disease Drugs Product and Services
Table 11. AiCuris Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AiCuris Recent Developments/Updates
Table 13. Sandoz Basic Information, Manufacturing Base and Competitors
Table 14. Sandoz Major Business
Table 15. Sandoz Anti-infectious Disease Drugs Product and Services
Table 16. Sandoz Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sandoz Recent Developments/Updates
Table 18. Anhui Jingfang Medical Industry Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 19. Anhui Jingfang Medical Industry Co.,Ltd Major Business
Table 20. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product and Services
Table 21. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Anhui Jingfang Medical Industry Co.,Ltd Recent Developments/Updates
Table 23. Beijing Double-Crane Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Beijing Double-Crane Pharmaceutical Co., Ltd. Major Business
Table 25. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product and Services
Table 26. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 28. Abbott Basic Information, Manufacturing Base and Competitors
Table 29. Abbott Major Business
Table 30. Abbott Anti-infectious Disease Drugs Product and Services
Table 31. Abbott Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Abbott Recent Developments/Updates
Table 33. Spero Therapeutics Basic Information, Manufacturing Base and Competitors
Table 34. Spero Therapeutics Major Business
Table 35. Spero Therapeutics Anti-infectious Disease Drugs Product and Services
Table 36. Spero Therapeutics Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Spero Therapeutics Recent Developments/Updates
Table 38. Adlyfe, Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Adlyfe, Inc. Major Business
Table 40. Adlyfe, Inc. Anti-infectious Disease Drugs Product and Services
Table 41. Adlyfe, Inc. Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Adlyfe, Inc. Recent Developments/Updates
Table 43. Advanced Life Sciences Holdings, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Advanced Life Sciences Holdings, Inc. Major Business
Table 45. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product and Services
Table 46. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Advanced Life Sciences Holdings, Inc. Recent Developments/Updates
Table 48. Affinium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Affinium Pharmaceuticals Major Business
Table 50. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product and Services
Table 51. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Affinium Pharmaceuticals Recent Developments/Updates
Table 53. APP Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. APP Pharmaceuticals Major Business
Table 55. APP Pharmaceuticals Anti-infectious Disease Drugs Product and Services
Table 56. APP Pharmaceuticals Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. APP Pharmaceuticals Recent Developments/Updates
Table 58. Aquapharm Biodiscovery Basic Information, Manufacturing Base and Competitors
Table 59. Aquapharm Biodiscovery Major Business
Table 60. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product and Services
Table 61. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Aquapharm Biodiscovery Recent Developments/Updates
Table 63. Basilea Pharmaceutica AG Basic Information, Manufacturing Base and Competitors
Table 64. Basilea Pharmaceutica AG Major Business
Table 65. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product and Services
Table 66. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Basilea Pharmaceutica AG Recent Developments/Updates
Table 68. Biophage Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Biophage Pharma, Inc. Major Business
Table 70. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product and Services
Table 71. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Biophage Pharma, Inc. Recent Developments/Updates
Table 73. Global Anti-infectious Disease Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Anti-infectious Disease Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Anti-infectious Disease Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Anti-infectious Disease Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Anti-infectious Disease Drugs Production Site of Key Manufacturer
Table 78. Anti-infectious Disease Drugs Market: Company Product Type Footprint
Table 79. Anti-infectious Disease Drugs Market: Company Product Application Footprint
Table 80. Anti-infectious Disease Drugs New Market Entrants and Barriers to Market Entry
Table 81. Anti-infectious Disease Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Anti-infectious Disease Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Anti-infectious Disease Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Anti-infectious Disease Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Anti-infectious Disease Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Anti-infectious Disease Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Anti-infectious Disease Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Anti-infectious Disease Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Anti-infectious Disease Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Anti-infectious Disease Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Anti-infectious Disease Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Anti-infectious Disease Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Anti-infectious Disease Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Anti-infectious Disease Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Anti-infectious Disease Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Anti-infectious Disease Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Anti-infectious Disease Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Anti-infectious Disease Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Anti-infectious Disease Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Anti-infectious Disease Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Anti-infectious Disease Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Anti-infectious Disease Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Anti-infectious Disease Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Anti-infectious Disease Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Anti-infectious Disease Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Anti-infectious Disease Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Anti-infectious Disease Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Anti-infectious Disease Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Anti-infectious Disease Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Anti-infectious Disease Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Anti-infectious Disease Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Anti-infectious Disease Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Anti-infectious Disease Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Anti-infectious Disease Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Anti-infectious Disease Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Anti-infectious Disease Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Anti-infectious Disease Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Anti-infectious Disease Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Anti-infectious Disease Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Anti-infectious Disease Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Anti-infectious Disease Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Anti-infectious Disease Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Anti-infectious Disease Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Anti-infectious Disease Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Anti-infectious Disease Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Anti-infectious Disease Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Anti-infectious Disease Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Anti-infectious Disease Drugs Raw Material
Table 141. Key Manufacturers of Anti-infectious Disease Drugs Raw Materials
Table 142. Anti-infectious Disease Drugs Typical Distributors
Table 143. Anti-infectious Disease Drugs Typical Customers
List of Figures
Figure 1. Anti-infectious Disease Drugs Picture
Figure 2. Global Anti-infectious Disease Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-infectious Disease Drugs Consumption Value Market Share by Type in 2022
Figure 4. Antibacterial Drugs Examples
Figure 5. Antifungal Drugs Examples
Figure 6. Antiviral Drugs Examples
Figure 7. Antiparasitic Drugs Examples
Figure 8. Global Anti-infectious Disease Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Anti-infectious Disease Drugs Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Institute of Medicine Examples
Figure 12. Clinic Examples
Figure 13. Others Examples
Figure 14. Global Anti-infectious Disease Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Anti-infectious Disease Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Anti-infectious Disease Drugs Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Anti-infectious Disease Drugs Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Anti-infectious Disease Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Anti-infectious Disease Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Anti-infectious Disease Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Anti-infectious Disease Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Anti-infectious Disease Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Anti-infectious Disease Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Anti-infectious Disease Drugs Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Anti-infectious Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Anti-infectious Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Anti-infectious Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Anti-infectious Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Anti-infectious Disease Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Anti-infectious Disease Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Anti-infectious Disease Drugs Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Anti-infectious Disease Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global Anti-infectious Disease Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Anti-infectious Disease Drugs Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Anti-infectious Disease Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America Anti-infectious Disease Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Anti-infectious Disease Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Anti-infectious Disease Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Anti-infectious Disease Drugs Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Anti-infectious Disease Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Anti-infectious Disease Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Anti-infectious Disease Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Anti-infectious Disease Drugs Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Anti-infectious Disease Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Anti-infectious Disease Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Anti-infectious Disease Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Anti-infectious Disease Drugs Consumption Value Market Share by Region (2018-2029)
Figure 56. China Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Anti-infectious Disease Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Anti-infectious Disease Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Anti-infectious Disease Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Anti-infectious Disease Drugs Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Anti-infectious Disease Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Anti-infectious Disease Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Anti-infectious Disease Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Anti-infectious Disease Drugs Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Anti-infectious Disease Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Anti-infectious Disease Drugs Market Drivers
Figure 77. Anti-infectious Disease Drugs Market Restraints
Figure 78. Anti-infectious Disease Drugs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Anti-infectious Disease Drugs in 2022
Figure 81. Manufacturing Process Analysis of Anti-infectious Disease Drugs
Figure 82. Anti-infectious Disease Drugs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source